Encompass Health Net Profit Margin 2010-2024 | EHC

Current and historical net profit margin for Encompass Health (EHC) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Encompass Health net profit margin for the three months ending September 30, 2024 was .
Encompass Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $5.22B $0.42B 8.11%
2024-06-30 $5.07B $0.40B 7.89%
2024-03-31 $4.96B $0.38B 7.61%
2023-12-31 $4.80B $0.35B 7.33%
2023-09-30 $4.69B $0.35B 7.53%
2023-06-30 $4.57B $0.31B 6.84%
2023-03-31 $4.45B $0.27B 6.09%
2022-12-31 $4.35B $0.27B 6.23%
2022-09-30 $3.70B $0.27B 7.41%
2022-06-30 $3.62B $0.33B 9.09%
2022-03-31 $3.84B $0.39B 10.22%
2021-12-31 $4.02B $0.41B 10.26%
2021-09-30 $3.67B $0.41B 11.08%
2021-06-30 $3.83B $0.38B 10.03%
2021-03-31 $3.61B $0.31B 8.44%
2020-12-31 $3.57B $0.29B 7.99%
2020-09-30 $4.61B $0.27B 5.79%
2020-06-30 $4.60B $0.29B 6.21%
2020-03-31 $4.66B $0.34B 7.36%
2019-12-31 $4.61B $0.36B 7.77%
2019-09-30 $4.52B $0.32B 7.04%
2019-06-30 $4.42B $0.31B 7.01%
2019-03-31 $4.36B $0.31B 7.14%
2018-12-31 $4.28B $0.29B 6.85%
2018-09-30 $4.19B $0.34B 8.11%
2018-06-30 $4.11B $0.32B 7.72%
2018-03-31 $4.00B $0.29B 7.19%
2017-12-31 $3.91B $0.27B 6.92%
2017-09-30 $3.84B $0.26B 6.80%
2017-06-30 $3.77B $0.26B 6.82%
2017-03-31 $3.71B $0.26B 6.93%
2016-12-31 $3.64B $0.25B 6.81%
2016-09-30 $3.58B $0.23B 6.43%
2016-06-30 $3.43B $0.22B 6.38%
2016-03-31 $3.28B $0.20B 6.07%
2015-12-31 $3.12B $0.18B 5.84%
2015-09-30 $2.86B $0.18B 6.16%
2015-06-30 $2.68B $0.17B 6.49%
2015-03-31 $2.52B $0.21B 8.45%
2014-12-31 $2.38B $0.22B 9.14%
2014-09-30 $2.34B $0.15B 6.38%
2014-06-30 $2.30B $0.15B 6.64%
2014-03-31 $2.27B $0.23B 10.15%
2013-12-31 $2.25B $0.23B 10.28%
2013-09-30 $2.23B $0.30B 13.48%
2013-06-30 $2.20B $0.29B 13.10%
2013-03-31 $2.17B $0.17B 7.80%
2012-12-31 $2.14B $0.16B 7.49%
2012-09-30 $2.09B $0.16B 7.75%
2012-06-30 $2.06B $0.17B 8.35%
2012-03-31 $2.04B $0.15B 7.22%
2011-12-31 $2.01B $0.18B 9.12%
2011-09-30 $1.95B $0.91B 46.87%
2011-06-30 $1.91B $0.89B 46.41%
2011-03-31 $1.87B $0.91B 48.74%
2010-12-31 $1.86B $0.87B 46.91%
2010-09-30 $1.78B $0.13B 7.42%
2010-06-30 $1.79B $0.12B 6.54%
2010-03-31 $1.80B $0.06B 3.55%
2009-12-31 $1.79B $0.07B 3.81%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.488B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.525B 11.81
Quest Diagnostics (DGX) United States $17.124B 17.35
DaVita (DVA) United States $12.715B 16.44
Chemed (CHE) United States $7.824B 24.05
Elanco Animal Health (ELAN) United States $5.873B 13.98
RadNet (RDNT) United States $5.431B 120.26
Option Care Health (OPCH) United States $3.882B 18.40
LifeStance Health (LFST) United States $2.789B 0.00
Amedisys (AMED) United States $2.789B 19.85
Addus HomeCare (ADUS) United States $2.337B 27.42
Astrana Health (ASTH) United States $1.883B 25.75
U.S Physical Therapy (USPH) United States $1.362B 35.82
Pennant (PNTG) United States $0.925B 37.42
Aveanna Healthcare Holdings (AVAH) United States $0.854B 0.00
Atai Life Sciences (ATAI) Germany $0.206B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.038B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00